Clinical Trials Logo

Clinical Trial Summary

Background: Vaso-active polyphenols have been proposed to enhance cognitive performance. Oral administration with the non-flavonoid polyphenol, resveratrol, has been found to modulate cerebral blood flow (CBF); yet, this has not resulted in subsequent predicted benefits to cognitive performance in young, healthy samples. It has been argued that ageing populations who are noted suffer a reduction in CBF and cognition, may possess the subtle deficits to benefit from resveratrol administration. The use of hypoxia has been previously tested by this research group to mimic the decrease in cognitive functioning associated with ageing.

Objectives: The current investigation aimed to further assess if a reduced fraction of inspired oxygen (12.7% FiO2) could provide an experimental model of aging in a young, healthy sample. Moreover, the current study also aimed to assess if resveratrol can attenuate the deficits elicited by the reduction in oxygen supply via increased CBF.

Design: This repeated measures, double blind, placebo controlled, balanced design assessed the cognitive and CBF effects of resveratrol in hypoxia (equivalent to 4000 m above sea level) and normoxia (sea level).

Methods: Twenty-four participants arrived fully fasted (except water) for 12 hours before completing a baseline measure of a cognitive task battery, and taking the treatment for the day (either 500 mg resveratrol or inert placebo). Following a 45 min absorption period, participants completed 3 full repetitions of a cognitive test battery. Changes in cerebral hemodynamics were measured by near-infrared spectroscopy throughout the full testing session.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03541993
Study type Interventional
Source Northumbria University
Contact
Status Completed
Phase N/A
Start date June 7, 2016
Completion date December 22, 2016

See also
  Status Clinical Trial Phase
Recruiting NCT05564949 - A Ketogenic Diet as a Complementary Treatment on Patients With High-grade Gliomas and Brain Metastases N/A
Recruiting NCT05372159 - Vanderbilt Memory and Aging Project
Completed NCT00026689 - Evaluation for NCI Radiation Oncology Branch Clinical Research Protocols
Completed NCT00246831 - Brain Networks Responsible for Self-Agency N/A
Not yet recruiting NCT04916652 - A First-ever Research Collaboration to Characterize MRI Measured Neural Flexibility Development in Chinese Toddlers
Completed NCT04646876 - Mgso4 as Neuroprotective in Post Traumatic Brain Injury Phase 3
Recruiting NCT05322343 - Biobank and Brain Health in Bordeaux.
Recruiting NCT04369755 - MR7T-Healthy-PTX : Brain Exploration in Magnetic Resonance Imaging in Parallel Transmission Mode (pTX) at 7 Tesla N/A
Completed NCT04317950 - Cortical Activity During Vojta Stimulation in Healthy Adults N/A
Completed NCT04726176 - COVID-19 and the Brain
Not yet recruiting NCT03781557 - Effects of Omega-3 Fatty Acids Supplement in Cognition of Young Healthy Adults and in Their Reaction Time of Computerized Test After 3 Months of Taking High-concentrated DHA and EPA Fish Softgels Phase 4
Completed NCT04288518 - Molecular Imaging of Brain Tumors Using Labeled Technetium-99m 1-Thio-D-Glucose. Phase 1/Phase 2
Recruiting NCT04208256 - Food Intake and the Adolescent Brain N/A
Terminated NCT03283150 - Deep Brain Stimulation (DBS) Sedation Phase 4
Completed NCT03268239 - Contrast-enhanced 3D T1-weighted Gradient-echo Versus Spin-echo 3 Tesla MR Sequences in the Detection of Active Multiple Sclerosis Lesions N/A
Recruiting NCT05843084 - The STEREO-DBS Study: 7-Tesla MRI Brain Network Analysis for Deep Brain Stimulation
Not yet recruiting NCT05170906 - Cerebral Oxygenation During Vojta Therapy in Healthy Adults Using Near-infrared Spectroscopy N/A